Guanidinosuccinic acid | CAS#6133-30-8 | metabolite in uremia

MedKoo Cat#: 596910 | Name: Guanidinosuccinic acid

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Guanidinosuccinic acid is a metabolite in uremia; metabolic product of amino acid metabolism.

Chemical Structure

Guanidinosuccinic acid

CAS#6133-30-8

Theoretical Analysis

MedKoo Cat#: 596910

Name: Guanidinosuccinic acid

CAS#: 6133-30-8

Chemical Formula: C5H9N3O4

Exact Mass: 175.0593

Molecular Weight: 175.14

Elemental Analysis: C, 34.29; H, 5.18; N, 23.99; O, 36.54

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Guanidinosuccinic acid; NSC 49078; NSC-49078; NSC49078; L-N-Amidinoaspartic acid;

IUPAC/Chemical Name

carbamimidoyl-L-aspartic acid

InChi Key

VVHOUVWJCQOYGG-REOHCLBHSA-N

InChi Code

InChI=1S/C5H9N3O4/c6-5(7)8-2(4(11)12)1-3(9)10/h2H,1H2,(H,9,10)(H,11,12)(H4,6,7,8)/t2-/m0/s1

SMILES Code

O=C(O)C[C@@H](C(O)=O)NC(N)=N

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 175.14 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Wei X, Yin Q, Zhao H, Cao Y, Cai C, Yao J. Metabolomics for the Effect of Biotin and Nicotinamide on Transition Dairy Cows. J Agric Food Chem. 2018 Jun 6;66(22):5723-5732. doi: 10.1021/acs.jafc.8b00421. Epub 2018 May 23. PubMed PMID: 29758980. 2: Chen S, Zhang M, Bo L, Li S, Hu L, Zhao X, Sun C. Metabolomic analysis of the toxic effect of chronic exposure of cadmium on rat urine. Environ Sci Pollut Res Int. 2018 Feb;25(4):3765-3774. doi: 10.1007/s11356-017-0774-8. Epub 2017 Nov 22. PubMed PMID: 29168138. 3: Qureshi MI, Greco M, Vorkas PA, Holmes E, Davies AH. Application of Metabolic Profiling to Abdominal Aortic Aneurysm Research. J Proteome Res. 2017 Jul 7;16(7):2325-2332. doi: 10.1021/acs.jproteome.6b00894. Epub 2017 Jun 19. Review. PubMed PMID: 28287739. 4: Zhang Y, Gu L, Jiang Y, Bi K, Chen X. Quantitative analysis of biomarkers of liver and kidney injury in serum and urine using ultra-fast liquid chromatography with tandem mass spectrometry coupled with a hydrophilic interaction chromatography column: Application to monitor injury induced by Euphorbiae pekinensis Radix. J Sep Sci. 2016 Oct;39(20):3936-3945. doi: 10.1002/jssc.201600470. Epub 2016 Sep 30. PubMed PMID: 27568578. 5: Zounr RA, Khuhawar MY, Jahangir TM, Alamgir M. Improved Gas Chromatographic Determination of Guanidino Compounds Using Isovaleroylacetone and Ethyl Chloroformate as Derivatizing Reagents. Anal Sci. 2016;32(2):141-6. doi: 10.2116/analsci.32.141. PubMed PMID: 26860556. 6: Gu L, Wang X, Zhang Y, Jiang Y, Lu H, Bi K, Chen X. Determination of 12 potential nephrotoxicity biomarkers in rat serum and urine by liquid chromatography with mass spectrometry and its application to renal failure induced by Semen Strychni. J Sep Sci. 2014 May;37(9-10):1058-66. doi: 10.1002/jssc.201400053. Epub 2014 Apr 10. PubMed PMID: 24610835. 7: Kasai Y, Akanuma S, Kubo Y, Tachikawa M, Hosoya K. Pharmacokinetics of guanidinosuccinic acid in rat blood and cerebrospinal fluid. Drug Metab Pharmacokinet. 2014;29(1):97-100. Epub 2013 Aug 13. PubMed PMID: 23955547. 8: Majidano SA, Khuhawar MY. Gas chromatographic analysis of guanidino compounds in sera and urine of uremic patients using glyoxal and ethyl chloroformate as derivatizing reagents. Anal Sci. 2013;29(2):221-6. PubMed PMID: 23400288. 9: Majidano SA, Khuhawar MY. Gas chromatographic determination of guanidino compounds in uremic patients using glyoxal as derivatizing reagent. J Chromatogr Sci. 2012 May;50(5):380-6. doi: 10.1093/chromsci/bms013. Epub 2012 Mar 5. PubMed PMID: 22392369. 10: Ciborowski M, Teul J, Martin-Ventura JL, Egido J, Barbas C. Metabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolic fingerprint. PLoS One. 2012;7(2):e31982. doi: 10.1371/journal.pone.0031982. Epub 2012 Feb 24. PubMed PMID: 22384120; PubMed Central PMCID: PMC3286447. 11: Toyohara T, Abe T. [Analysis of transporter function and development to clinical application]. Seikagaku. 2011 Apr;83(4):323-8. Review. Japanese. PubMed PMID: 21626887. 12: Tachikawa M, Hosoya K. Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders. Fluids Barriers CNS. 2011 Feb 28;8(1):13. doi: 10.1186/2045-8118-8-13. PubMed PMID: 21352605; PubMed Central PMCID: PMC3058069. 13: Schepers E, Glorieux G, Dou L, Cerini C, Gayrard N, Louvet L, Maugard C, Preus P, Rodriguez-Ortiz M, Argiles A, Brunet P, Cohen G, Jankowski J, Jankowski V, Massy Z, Rodriguez M, Vanholder R; European Uremic Toxin Work Group (EUTox). Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. Blood Purif. 2010;30(4):277-87. doi: 10.1159/000320765. Epub 2010 Nov 16. PubMed PMID: 21079396. 14: Saigusa D, Suzuki N, Takahashi M, Shiba K, Tanaka S, Abe T, Hishinuma T, Tomioka Y. Simultaneous determination of guanidinosuccinic acid and guanidinoacetic acid in urine using high performance liquid chromatography/tandem mass spectrometry. Anal Chim Acta. 2010 Sep 16;677(2):169-75. doi: 10.1016/j.aca.2010.08.005. Epub 2010 Aug 13. PubMed PMID: 20837184. 15: De Deyn PP, Vanholder R, Eloot S, Glorieux G. Guanidino compounds as uremic (neuro)toxins. Semin Dial. 2009 Jul-Aug;22(4):340-5. doi: 10.1111/j.1525-139X.2009.00577.x. Review. PubMed PMID: 19708978. 16: Ienaga K, Mikami H, Yokozawa T. First indications demonstrating the preventive effects of NZ-419, a novel intrinsic antioxidant, on the initiation and/or progression of chronic renal failure in rats. Biol Pharm Bull. 2009 Jul;32(7):1204-8. PubMed PMID: 19571386. 17: Eloot S, van Biesen W, Dhondt A, de Smet R, Marescau B, De Deyn PP, Verdonck P, Vanholder R. Impact of increasing haemodialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis. Nephrol Dial Transplant. 2009 Jul;24(7):2225-32. doi: 10.1093/ndt/gfp059. Epub 2009 Feb 18. PubMed PMID: 19225018. 18: Levillain O, Marescau B, Possemiers I, De Deyn PP. Accumulation of methylguanidine and changes in guanidino compound levels in plasma, urine, and kidneys of furosemide-treated rats. Metabolism. 2008 Jun;57(6):802-10. doi: 10.1016/j.metabol.2008.01.025. PubMed PMID: 18502263. 19: Taes YE, Marescau B, De Vriese A, De Deyn PP, Schepers E, Vanholder R, Delanghe JR. Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol Dial Transplant. 2008 Apr;23(4):1330-5. Epub 2007 Nov 29. PubMed PMID: 18048424. 20: Eloot S, Torremans A, De Smet R, Marescau B, De Deyn PP, Verdonck P, Vanholder R. Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis. 2007 Aug;50(2):279-88. PubMed PMID: 17660029.